Analystreport

Prestige Consumer Healthcare Inc. (NYSE: PBH) had its price target raised by analysts at DA Davidson from $93.00 to $95.00. They now have a "buy" rating on the stock.

Prestige Consumer Healthcare Inc.  (PBH) 
Last prestige consumer healthcare inc. earnings: 2/6 06:00 am Check Earnings Report
US:NYSE Investor Relations: ir.prestigebrands.com